| |
|
|
|
Cleveland Biolabs  
|
|
2.5389 0.069 (0.03%) |
08-05 13:00 |
|
Open: |
2.58 |
Pre close: |
2.47 |
Target:
|
3.50
|
|
High: |
2.58 |
Low: |
2.5 |
Resistance:
|
3.00
3.65
|
|
Volume: |
216,923 |
Market Cap: |
33M |
Support:
|
1.95
1.62
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.46
 |
MACD |
MACD(12,26):
|
0.07  |
|
MA(20): |
2.57 |
Signal(12,26,9): |
0.11 |
|
MA(100): |
1.98 |
Stochastic Oscillator |
%K(14,3):
|
25.33 |
|
MA(250): |
1.58 |
%D(3): |
26.43 |
|
Average Volume(K) |
3-Month: |
158078
|
52-Week |
High:
|
5.00 |
|
10-Days: |
22074 |
Low: |
0.50 |
|
RSI |
RSI(14):
|
51.90 |
Change(%): |
78.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.209 |
Return on Equity (ttm) |
-135.7 |
Shares Out. (M) |
12.92 |
|
EPS Est. Current Year |
-0.160 |
Return on Assets (ttm) |
-44.6 |
Shares Float (M) |
4.92 |
|
EPS Est. Next Year |
-0.480 |
PEG Ratio |
0.00 |
% Held by Insiders |
64.39 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-21.2 |
% Held by Institutions |
3.68 |
|
Forward EPS |
-0.280 |
Gross Profit (p.s.) |
-0.042 |
Shares Short (K) |
527 |
|
Book Value (p.s.) |
-0.370 |
EBITDA (p.s.) |
-0.155 |
P/E |
-12.06 |
|
Sales Per Share |
0.083 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-6.81 |
|
Profit Margin |
-220.48 |
Operating Cash Flow
(M) |
-2.26 |
P/S |
30.43 |
|
Operating Margin |
-188.05 |
Levered Free Cash Flow
(M) |
-1.45 |
P/CF |
-14.41 |
|
|
|
|
|
|
